Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico. - Test2 - elhamkhani - TriplyDB

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

http://www.wikidata.org/entity/Q30145646

about

Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.Monoclonal antibodies against Zika virus: Therapeutics and their implications for vaccine design.Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design.Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.Zika virus: what we need to know?Zika Virus: An Emerging Global Health Threat.Development of envelope protein antigens to serologically differentiate Zika from dengue virus infection.Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.Immune Response to Dengue and Zika.Development of Antibody Therapeutics against Flaviviruses.The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.Redefining priorities towards graded travel-related infectious disease research.What Is a Host? Attributes of Individual Susceptibility.The immunology of Zika Virus.Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.Longitudinal Analysis of Antibody Cross-Neutralization Following Zika and Dengue Virus Infection in Asia and the Americas.Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.Zika convalescent macaques display delayed induction of anmanestic cross-neutralizing antibody responses after dengue infection.Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein Critical role of CD4 T cells and IFNγ signaling in antibody-mediated resistance to Zika virus infection Complementary Mechanisms Potentially Involved in the Pathology of Zika Virus Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans

P2860

Q38156536-BD949CE6-1BF8-4829-A4D0-C74B1AD8B718 Q38156674-6D0CF3E6-C741-4516-9ECC-3B2655FDE96F Q38157121-446F7913-4119-4C36-8B95-594567772BE8 Q38158099-82E1F8F4-5DEA-430C-B7EC-1DAE92FA534E Q38158407-C6F3AA15-3AFA-486B-A28E-54AEB68235B5 Q40043685-E3229AE2-D716-4CDE-B183-564BDBF01402 Q41921198-B43059AD-3C75-4F1F-9CC0-376B606CC1E4 Q41929032-2770F6EC-F633-4839-8F51-BB9FA6D54125 Q44169814-A9528153-021B-4A48-92CC-1CE1B6C5B9FA Q47130545-04ED2233-18ED-426E-96D8-ED1C640F7056 Q47269331-830A2B63-4B35-4981-B80C-7FC3A8EF3EDE Q47548101-72E28222-A3B1-46C6-B2DC-E6A5570E416D Q47551925-999EFA52-281C-4EA5-B8CE-AB45D7DED993 Q47558158-A98F78D7-61E5-4E5A-BE37-E9BBDF818FE9 Q47558217-ED31CE9D-A21B-4634-A86B-F632AE5E127F Q47558315-76F73DF1-A54E-48CA-AF65-DF07A22BCF2C Q47681827-93C6AFF2-878B-4B43-9068-F673EC443B61 Q48101193-9B8DEDDB-F545-4688-B257-F4EF0F67DCFE Q51336389-4DBD964F-2A0D-4037-83F2-9E31D889FD4D Q51336680-E8A63802-960B-43F4-9B71-69CB03BE0EFC Q54215484-57828A26-488A-4839-82DD-2138D74E13C5 Q54217627-936C6BF6-8ECC-4CAB-98E8-D87F71F363D1 Q54241921-C4AEC67A-FD63-4D21-B4C7-BB9D7FD450C8 Q54265465-ED2908A5-69F3-493A-8742-17DB8FC7AB19 Q55645060-4084E47D-4543-4185-B979-D2FCD8F42B6C Q56000963-A221FBEE-E94F-41AC-9AAB-C727124093BC Q56341683-C0F734D6-C371-4A49-9BFA-2D6B5871D269 Q58122069-5E3E62A4-AC85-48C9-8D45-16D9FD9AB41B Q58569620-65257B4C-0789-4708-87A4-A053A33021B4 Q58744078-34B1777C-3900-4221-93EC-45AF7D17FF45 Q58758276-F80E8FE6-046A-4118-A77C-288070AAD5DE

P2860

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

http://www.wikidata.org/entity/Q30145646

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@ast

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@en

type

label

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@ast

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@en

altLabel

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

@en

prefLabel

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@ast

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@en

P1433

Q30145646-1F628E32-7703-40D7-8D02-7F200590108D

P1476

Q30145646-4BBBC506-382C-4215-A1F4-0B99ED99F17F

P2093

Q30145646-14F98FD7-1B94-4D4D-A534-2543A61035D2

Q30145646-1670D65B-1B8E-4EE4-978D-3034D7AD70C1

Q30145646-23CF1E86-1A23-4AEC-A844-937ABEBC9335

Q30145646-4A0CE187-6169-4445-B2F7-7D6956779874

Q30145646-4D3956F5-D602-4397-9616-2D972F837C4C

Q30145646-71A8C8EB-4144-4C0D-8BE8-FAD618BA726E

Q30145646-75D60B49-74D1-460E-9FF1-E1D2EF9DDA02

Q30145646-7C738BD9-AB18-4D8B-9A59-F211361EDDC7

Q30145646-7CAE8CF8-B742-49C7-A318-FE05EB7A4E4D

Q30145646-802D653F-8607-40C5-92D2-6BE54379D969

P2860

Q30145646-01312F8F-4CFD-4ED4-9942-93C8735CEF93

Q30145646-0194CEC3-0116-4A9C-AFDB-1E81FB3EE1CF

Q30145646-051018D9-778F-487F-A672-59D0F0B86B22

Q30145646-0535EB53-519A-4BA6-8651-A4703DAE53B6

Q30145646-0799BD9D-738A-4E9F-8C5D-C5BBFC08C4DD

Q30145646-07F70E9A-2BAA-4D49-BFEA-0EB54D6A44F0

Q30145646-0809A3E8-C419-416F-AF6F-C084F2242E34

Q30145646-0F477820-F265-4CB1-9C61-B7A77C4D3E64

Q30145646-18A60FBA-8AD6-4855-9E8C-87095295ED64

Q30145646-19C53FAD-3EF4-4545-96A0-C03A1215DC87

P304

Q30145646-D8FF6865-A64A-47B4-95EE-8B768F11295D

P31

Q30145646-F6EA8550-723F-486F-A7A7-B21411A09375

P356

Q30145646-B788518C-418A-41AC-B745-2D5928092D6D

P407

Q30145646-48A9A57E-4D1D-4545-8E9C-FFEF2DD64366

P433

Q30145646-BECB6D12-8D75-40A9-8441-1CA6A63282D5

P478

Q30145646-78E0D3CF-3C9D-4FC1-A8E9-D688FAC978A6

P50

Q30145646-0E942611-52BC-4660-BCC1-A8B2E722DE2C

Q30145646-48D77220-7EC0-4929-B467-FD32E4FA88FD

Q30145646-6008FE91-BCC6-4886-B4DC-51F2933AA4C9

Q30145646-92BDA38E-EFF5-4643-BDFC-3C1F23DA5F15

Q30145646-CDA97486-CEF0-4019-9EDC-67B65F138DAC

Q30145646-D14A7965-29E3-49D1-B49D-2DD6573D202C

Q30145646-DB3044F1-B822-4726-BF66-60D67EC13DB7

Q30145646-E6F47EA7-FD7A-4EB0-B448-8283C1331A6C

P5008

Q30145646-3D9226FB-4272-4AB9-90B3-F8E35BB90536

P577

Q30145646-40BFA689-19CA-4068-8F66-85D80044CBB1

P698

Q30145646-03EB4636-4E73-4E91-B5F6-718AA29310D6

P921

Q30145646-2FFAF561-1C5A-4668-A724-7B0A18C7A416

Q30145646-4B6F3D93-C179-478D-90AB-6D3D1FFDD0A7

Q30145646-B1854940-41B2-4CCD-B2A4-8015063837C8

Q30145646-FDAA7660-3000-4C10-A704-FADE127B5117

P932

Q30145646-AC297F19-E5AC-47BD-B732-3BA9D80A65EA

P356

J.CELL.2017.04.024

P1433

P1476

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

@en

P2093

Anna Gazumyan

http://www.w3.org/2001/XMLSchema#string

Anthony P West

http://www.w3.org/2001/XMLSchema#string

Antonio R P de Almeida

http://www.w3.org/2001/XMLSchema#string

Arlene Hurley

http://www.w3.org/2001/XMLSchema#string

Charles M Rice

http://www.w3.org/2001/XMLSchema#string

Cibele Orge

http://www.w3.org/2001/XMLSchema#string

Daniel M Weinberger

http://www.w3.org/2001/XMLSchema#string

Dennis Schaefer-Babajew

http://www.w3.org/2001/XMLSchema#string

Edgar E Sevilla-Reyes

http://www.w3.org/2001/XMLSchema#string

Federico Costa

http://www.w3.org/2001/XMLSchema#string

P2860

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Probable non-vector-borne transmission of Zika virus, Colorado, USA

Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil

Zika Virus Infection in Pregnant Women in Rio de Janeiro — Preliminary Report

The 3.8 Å resolution cryo-EM structure of Zika virus

Phylogeny of Zika Virus in Western Hemisphere, 2015

Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody

Structure of the thermally stable Zika virus

Emergence of Congenital Zika Syndrome: Viewpoint From the Front Lines

Zika virus: History, emergence, biology, and prospects for control

P304

597-609.e11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CELL.2017.04.024

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Thiago Y Oliveira

Priscilla Christina Olsen

P5008

WikiProject Zika Corpus

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28475892

http://www.w3.org/2001/XMLSchema#string

P921

2015–16 Zika virus epidemic

P932

5492969

http://www.w3.org/2001/XMLSchema#string